Skip to main content
. 2022 Dec 8;131:106316. doi: 10.1016/j.bioorg.2022.106316

Fig. 7.

Fig. 7

(A) With addition of BA-4 (20 uM), Co-IP assays showed no affection of the binding of SARS-CoV-2 S protein and ACE2 (anti-Flag). (B) BA-4 inhibited SARS-CoV-2 Omicron mutant infection via blocking Omicron protein-mediated membrane fusion. (C) SPR analysis of the interaction between BA-4 with Omicron S2. (D) SPR analysis of the interaction between BA-4 with Omicron S1.